- Report
- March 2024
- 195 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- May 2023
- 110 Pages
Global
From €5717EUR$5,950USD£4,908GBP
- Report
- October 2023
- 110 Pages
Global
From €5717EUR$5,950USD£4,908GBP
- Report
- May 2024
- 504 Pages
Global
From €5237EUR$5,450USD£4,495GBP
- Report
- November 2023
- 142 Pages
Global
From €2401EUR$2,499USD£2,061GBP
- Report
- February 2024
- 115 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- December 2023
- 140 Pages
Global
From €4276EUR$4,450USD£3,671GBP
- Report
- January 2024
- 200 Pages
Global
From €3987EUR$4,150USD£3,423GBP
- Report
- October 2021
- 61 Pages
Global
From €4756EUR$4,950USD£4,083GBP
- Report
- August 2022
- 330 Pages
Global
From €3060EUR$3,185USD£2,627GBP
€4372EUR$4,550USD£3,753GBP
- Report
- November 2021
- 181 Pages
Global
From €5926EUR$6,168USD£5,088GBP
- Report
- May 2023
- 147 Pages
Global
From €5764EUR$5,999USD£4,948GBP
- Book
- November 2020
- 574 Pages
- Book
- August 2018
- 1524 Pages
- Book
- June 2018
- 208 Pages
Cerebral Palsy (CP) is a neurological disorder that affects movement, posture, and coordination. It is caused by damage to the developing brain, usually before or during birth. CP is a lifelong condition that can range from mild to severe, and can affect physical, cognitive, and social functioning.
The therapeutic area for CP is focused on improving the quality of life for those affected. Treatment options include physical, occupational, and speech therapy, as well as medications, assistive devices, and surgery. There is also a focus on providing support and education to families and caregivers.
Companies in the CP market include AbbVie, Biogen, GlaxoSmithKline, Novartis, Pfizer, and Sanofi. These companies are involved in the development of medications, therapies, and assistive devices to help those with CP. Show Less Read more